Skip to Content
Merck
All Photos(1)

Key Documents

EZPIIANP

Millipore

Human Type IIA Collagen N-Propeptide ELISA Kit

measures PIIANP in 5 μL plasma

Synonym(s):

Collagen alpha-1 Type II chain

Sign Into View Organizational & Contract Pricing
All Photos(1)

About This Item

UNSPSC Code:
12161503
eCl@ss:
32161000
NACRES:
NC.07

product name

Type IIA Collagen N-Propeptide (PIIANP) ELISA,

species reactivity

human

Quality Level

200

packaging

kit of 1 × 96 wells

parameter

5 μL sample volume (4hr assay)

assay range

accuracy: 97-112%
linearity: 91-109%
sensitivity: 39 ng/mL

technique(s)

ELISA: suitable

input

sample type plasma (K2 EDTA)

NCBI accession no.

NM_001844.4
NM_033150.2

UniProt accession no.

P02458

application(s)

research use

detection method

colorimetric (450nm/590nm)

shipped in

wet ice

storage temp.

2-8°C

Gene Information

human ... COL2A1(1280)

General description

Type II collagen is the major collagen found in cartilage and is expressed in two forms: IIA and IIB.

Specificity

Cross Reactivty
No cross-reactivity observed with intact Type I, Type II and Type III collagen and procollagen
Human PIIANP 100%

Application

Research Category
Metabolism
Research Sub Category
Obesity

Metabolic Disorders
Room temperature, 3 hour assay 10 µL sample size
Used to detect/quantify: PIIANP

Other Notes

Standard curve range: lot dependent

Disclaimer

For research use only. Not for use in diagnostic procedures.

Signal Word

Danger

Hazard Classifications

Acute Tox. 1 Dermal - Acute Tox. 2 Inhalation - Acute Tox. 3 Oral - Aquatic Acute 1 - Aquatic Chronic 1 - Met. Corr. 1 - Skin Sens. 1 - STOT RE 2 Oral

Target Organs

Brain

Supplementary Hazards

EUH032

Storage Class Code

6.1A - Combustible acute toxic Cat. 1 and 2 / very toxic hazardous materials

Certificates of Analysis (COA)

Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Femke Intema et al.
Annals of the rheumatic diseases, 70(8), 1441-1446 (2011-05-14)
Modification of joint tissue damage is challenging in late-stage osteoarthritis (OA). Few options are available for treating end-stage knee OA other than joint replacement. To examine whether joint distraction can effectively modify knee joint tissue damage and has the potential

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service